Dr. Jason Franasiak Podcast on The Human Microbiome and Human Reproduction

NEEDHAM, Mass. - May 26, 2016 - PRLog -- Cambridge Healthtech Institute (CHI) releases today a podcast with Jason Franasiak, M.D., FACOG, Attending Physician at Reproductive Medicine Associates of New Jersey. Dr. Franasiak discusses the origins of germ theory and human microbiome research, specifically as it relates to human reproduction. Some of his research on the uteran microbiome during embryo implantation, future developments for diagnostics, and how other scientists may utilize his research and apply it to their own studies is explained.

Copy/Paste this URL to listen to the podcast: http://www.nextgenerationdx.com/NextGeneration_content.aspx?id=162563

Dr. Franasiak will present at the "Advances in Microbiome Diagnostics" symposium, taking place August 26, 2016 in Washington, DC--as part of the Next Generation Dx Summit. For details, visit http://www.NextGenerationDx.com/Microbiome-Diagnostics.

About Dr. Jason Franasiak:
Dr. Franasiak is a board-certified Obstetrician and Gynecologist and lead physician of RMA's South Jersey - Marlton Office. He has been invited to speak nationally and internationally and has authored and contributed to over 100 peer reviewed publications, published chapters and abstracts. He serves on the Editorial Board for Fertility and Sterility and the British Journal of Obstetrics and Gynecology. He also serves as Ad Hoc Reviewer for the Journal of Assisted Reproduction Genetics, Human Genetics, Reproductive BioMedicine Online, Human Reproduction, and Reproductive Biology and Endocrinology. Dr. Franasiak volunteers as an OB/GYN Clinical Advisor for Osmosis - Integrated Medical Learning and with Kaplan Test Prep for USMLE Step, 1, 2, and 3 reproductive medicine coursework.

About Cambridge Healthtech Institute (healthtech.com)
Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Preclinical Congress, Next Generation Dx Summit and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation, Bio-IT World, Clinical Informatics News and Diagnostics World.

Contact:
For media inquiries, or to arrange an interview with Dr. Franasiak, contact:
James Prudhomme
Cambridge Healthtech Institute (CHI)
781-972-5400
jprudhomme@healthtech.com